Ejaculatory Preserving Middle Lobe Onl-Transurethral Resection and Vaporization of the Prostate: 12-Year Experience.

Abstract

OBJECTIVE:

To report long-term safety and efficacy data on middle lobe only-transurethral resection of the prostate (TURP) (MLO-TURP).

MATERIALS AND METHODS:

We evaluated: (1) efficacy: International Prostate Symptom Score, Quality of Life, peak flow rate (Qmax), postvoid residual urine, International Index of Erectile Function and ejaculatory function, which was assessed by the Male Sexual Health Questionnaire. Men were evaluated at 1 month, 6 months, and yearly thereafter.

RESULTS:

A total 312 men (mean age 61.3 ± 8.6) with significant lower urinary tract symptoms (n = 147) or urinary retention (n = 175 were treated with MLO-TURP from 2005 to 2017. Mean baseline prostate volume was 79.8 g (30-178 g); mean baseline intravesical-prostatic protrusion was 13.6. Improvements in International Prostate Symptom Score, Quality of Life, Qmax and postvoid residual urine were durable throughout the study period. There was no difference in outcomes between monopolar and bipolar MLO-TURPs. Postoperatively, the incidence of ejaculatory dysfunction was 2.6% (N = 8) and there was 1 case of new onset ED (0.3%). There were modest improvement in bother due to ejaculatory function (baseline: 2.4 and at 5 years: 1.27).

CONCLUSION:

MLO-TURP is a safe and effective treatment for men with lower urinary tract symptoms. Patients experience long-term improvement of symptoms and preserve antegrade ejaculation. In select men with prominent middle lobes, MLO-- should be considered a therapeutic, ejaculation-sparing option.

• Authors: Zeynep Gul, Bilal Chughtai, Alexis E Te, Dominique Thomas, Steven A Kaplan
• Journal: Urology (Urology) Vol. 134 Pg. 199-202 (12 2019) ISSN: 1527-9995 [Electronic] United States
• PMID: 31563537 (Publication Type: Journal Article)
• Copyright: Copyright © 2019 Elsevier Inc. All rights reserved.

Topics

• Aged
• Aged, 80 and over
• Dysuria (etiology)
• Ejaculation
• Follow-Up Studies
• Humans
• Laser Therapy (adverse effects)
• Lower Urinary Tract Symptoms (etiology, surgery)
• Male
• Middle Aged
• Postoperative Complications
• Prostate (surgery)
• Prostatic Hyperplasia (surgery)
• Quality of Life
• Transurethral Resection of Prostate (adverse effects, methods)
• Urinary Catheterization
• Urinary Retention (surgery)
• Urinary Tract Infections (etiology)